TScan Therapeutics, Inc. (TCRX) Tops Q2 EPS by 5c
Go back to TScan Therapeutics, Inc. (TCRX) Tops Q2 EPS by 5c| Dreyfus/Laurel Funds Trust Dreyfus Core Value Fund Class I (NASDAQ: TCRX) | Delayed: 0.80 +0.04 (5.26%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.76 | 52 Week High | $26.80 | |||
| Open | $0.75 | 52 Week Low | $23.00 | |||
| Day High | $0.80 | P/E | N/A | |||
| Day Low | $0.75 | EPS | $0.00 | |||
| Volume | 336,331 | |||||
